Cardiac iPSCs for Drug Discovery

Video   Apr 27, 2016

 

Heart disease is the cause of morbidity and mortality in the industrialized world. While the use of human induced pluripotent stem cell (iPSCs) in regenerative medicine is a long-term goal. Recent technological advancement has enabled the generation of patient-specific and disease-specific human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) in vitro. iPSC-CMs carry all the genetic information and therefore may be an ideal platform for elucidating disease modeling, drug screening, and cell therapy. Here I will discuss recent advances in this technology in the cardiovascular field.

 
Company Information
 
 
 

Recommended Videos

PerkinElmer VICTOR Nivo Multimode Plate Reader - So Much Science So Little Bench Space

Video

The VICTOR Nivo system: The next big thing in plate readers is now the smallest.

WATCH NOW

How does a medicine get from the lab to patients?

Video

How is a new medicine for your disease approved by the European Medicines Agency?

WATCH NOW

LeNeo - Fusion Instrument

Video

LeNeo fusion instrument is an automatic and single position electrical instrument that prepares glass disks for XRF as well as solutions (borate and peroxide) for AA and ICP analysis.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE